Skip to main content
Fig. 8 | Journal of Translational Medicine

Fig. 8

From: Determining the prognostic significance of alternative splicing events in soft tissue sarcoma using data from The Cancer Genome Atlas

Fig. 8

Meta-analyses conducted to evaluate the mRNA levels of MDM2, EWSR1, CDKN2A, and HMGA2 in soft tissue sarcoma and normal controls. For RNA-Seq data, 257 STS samples were collected from TCGA, and 448 normal mesenchymal tissues from the GTEx database were chosen as normal controls. For the Affymetrix data, 57 STS samples and 730 normal controls were included. For the Illumina data, 12 STS samples and 111 normal controls were ultimately included. SMD standard mean difference, 95% CI 95% confidence interval, TCGA The Cancer Genome Atlas, GTEx genotype-tissue expression project

Back to article page